Katharin Czink

2 weeks ago | wgntv.com | Dina Bair |Katharin Czink

Medical Watch Digest for May 22The White House released a report on American’s health. it’s called MAHA or “Making Our Children Healthy Again.”The report says today’s children are the sickest generation in American history in terms of chronic disease. It blames environmental toxins, poor nutrition and increased screen time for a decline in life expectancy. And it casts doubt on vaccinations and medications that most in mainstream medicine consider to be safe.

3 weeks ago | newsnationnow.com | Katharin Czink |Dina Bair

CHICAGO ( WGN) - Researchers at Northwestern University say a new wearable device they've developed can help ease the anxiety many moms experience over how much breast milk their baby is consuming at each feeding. Biomedical engineer John Rogers and his team previously invented soft, wireless wearables that monitor infants' vital signs in the neonatal intensive care unit. He called their new device that focuses on moms "embarrassingly simple" to use. "They just stick to the surface of the skin.

3 weeks ago | wgntv.com | Dina Bair |Katharin Czink

Biomedical engineer creates device that offers real-time consumption data to moms during breastfeeding CHICAGO (WGN) — Researchers at Northwestern University say a new wearable device they’ve developed can help ease the anxiety that many moms experience by not knowing how much breast milk their baby is consuming at each feeding.

3 weeks ago | wgntv.com | Dina Bair |Katharin Czink

CHICAGO (WGN) — What you see is what you get! That’s how patients often feel after undergoing cataract surgery. Now, an adjustable lens is giving older adults the best vision of their lives. “The lens of the eye, when we’re born, is this: it bends light rays and it’s nice and clear,” said Dr. Madhu Gorla, an ophthalmologist at Chicago Glaucoma Consultants. As we age, it gets cloudy, a sign of cataracts. “This definitely gets in the way of a patient’s vision,” Gorla said.

3 weeks ago | wgntv.com | Dina Bair |Katharin Czink

For Monday, May 12, WGN’s Dina Bair has the latest on new medical information, including:In the first head-to-head study, researchers tracked people living with obesity who take Tirzepatide, also known as Mounjaro, and others who take Semaglutide, or Ozempic. Now that the drugs are more commonly prescribed, the European Society for the Study of Obesity looked at patients after 72 weeks. There was one clear winner. Mounjaro helped people achieve 50% more weight loss than Ozempic.